Archives for April 2016

Statement delivered by the Deputy Permanent Representative Mr. Menelaos Menelaou

Peace consolidation in West Africa: Piracy and Armed Robbery at Sea in the Gulf of Guinea

Thank you Mr. President.

Cyprus aligns itself with the statement delivered by the European Union and wishes to add the following in its national capacity. At the outset, we wish to commend the Chinese Presidency of the Security Council as well as Angola and Senegal for their initiative to organize this open debate on piracy and armed robbery with a particular focus on the Gulf of Guinea, one of the regions that are most affected by this threat. [Read more…]

High-level Signature Ceremony for the Paris Agreement

New York, 22 April 2016

Your Excellencies,

Distinguished delegates,

Distinguished guests,

Ladies and gentlemen,

Firstly, I would like to express my appreciation to the UN Secretary General for hosting this important event in New York.

[Read more…]

Statement by Special Ministerial Envoy, Ambassador Andreas Mavroyiannis

New York, 21 April 2016

Mr. President,

Thank you for convening this important HL meeting, the first following the adoption of the universal, transformative 2030 Agenda and the Sustainable Development Goals last September. [Read more…]

Special Session of the United Nations General Assembly on the World Drug Problem

General Debate, 21 April 2016

Mr. Chairman, Excellencies, Ladies and Gentlemen, my delegation subscribes to the statement delivered by the European Union.

 I would like to add some remarks in my national capacity. I appreciate the opportunity to address on behalf of the Republic of Cyprus this high level meeting which aims to address all the achievements put forward since the 2009 “Political Declaration and Plan [Read more…]

Special Session of the UN General Assembly on the World Drug Problem

New York, 19-21 April 2016

Round Table 1 (19 April, 3:00 p.m. to 6:00 p.m.): Demand Reduction and related measures, including prevention and treatment, as well as health-related issues, and ensuring the availability of controlled substances for medical and scientific purposes, while preventing their diversion (“drugs and health”) [Read more…]